Search by Drug Name or NDC
NDC 63323-0373-02 Ondansetron 2 mg/mL Details
Ondansetron 2 mg/mL
Ondansetron is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is ONDANSETRON HYDROCHLORIDE.
MedlinePlus Drug Summary
Ondansetron injection is used to prevent nausea and vomiting caused by cancer chemotherapy and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
Related Packages: 63323-0373-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ondansetron Injection
Product Information
NDC | 63323-0373 |
---|---|
Product ID | 63323-373_83824969-e116-40d6-8940-ff134a4f16c0 |
Associated GPIs | 50250065052024 |
GCN Sequence Number | 061716 |
GCN Sequence Number Description | ondansetron HCl/PF VIAL 4 MG/2 ML INJECTION |
HIC3 | H6J |
HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
GCN | 97502 |
HICL Sequence Number | 033598 |
HICL Sequence Number Description | ONDANSETRON HCL/PF |
Brand/Generic | Generic |
Proprietary Name | Ondansetron |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | ONDANSETRON HYDROCHLORIDE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | INTRAMUSCULAR; INTRAVENOUS |
Active Ingredient Strength | 2 |
Active Ingredient Units | mg/mL |
Substance Name | ONDANSETRON HYDROCHLORIDE |
Labeler Name | Fresenius Kabi USA, LLC |
Pharmaceutical Class | Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA076972 |
Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0373-02 (63323037302)
NDC Package Code | 63323-373-02 |
---|---|
Billing NDC | 63323037302 |
Package | 25 VIAL in 1 TRAY (63323-373-02) / 2 mL in 1 VIAL (63323-373-00) |
Marketing Start Date | 2009-11-18 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.19749 |
Pricing Unit | ML |
Effective Date | 2023-08-23 |
NDC Description | ONDANSETRON HCL 4 MG/2 ML VIAL |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 4, 5 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis